A study has demonstrated the high accuracy of plasma p-tau217 as a blood-based biomarker for detecting abnormal brain beta-amyloid pathology, a hallmark of Alzheimer's disease.
from Top Health News -- ScienceDaily https://ift.tt/Td08jMf
the news of the day, for today, top news of today, world news today live, top local news, top news stories of the day, top news today in the world, news today nyc, top news today local,
Subscribe to:
Post Comments (Atom)
FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune diseases, without chemotherapy
FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001...
-
Researchers observed a rise in adult central nervous system (CNS) infections, primarily aseptic meningitis caused by the varicella zoster vi...
-
Each brain is unique, not only in its connections but also in the molecular composition of its neurons, particularly ion channels. Despite t...
-
Over half of our genomes consists of thousands of remnants of ancient viral DNA, known as transposable elements, which are widespread across...
No comments:
Post a Comment